We describe a further simplification of a dipstick assay for the detection of antibodies to phenolic glycolipid I of Mycobacterium leprae by using whole blood and evaluated the assay performance in the leprosy endemic area of Amazonas in Brazil. The agreement with the`gold' standard ELISA was 94.9% (U value = 0.87). This simple assay may be useful to identify those at risk of developing leprosy, for example among contacts of leprosy patients at lower levels in the health services. z
Introduction
The introduction of relatively short treatment regimens for leprosy, an infection caused by Mycobacterium leprae, has resulted in a sharp decrease of the number of registered leprosy patients in the world [1] . Notwithstanding the approximately constant number of new cases detected world-wide every year, leprosy seems thereby to have been reduced to a tangible health problem. Health reforms combined with the recent push to further eliminate leprosy as a public health problem [1] will result in decentralization of leprosy control services and their integration into general health services. Health workers in non-specialized peripheral facilities will have to be able to diagnose the disease and monitor treatment results.
Elevated antibody levels to the phenolic glycolipid I (PGL-I) antigen of M. leprae indicate a risk for developing disease, as well as the type, transmission and extent of the disease [2] . Detection of antibodies may assist in diagnosis of leprosy and mostly recognition of potential multibacillary (MB) cases among contacts.
An operational role for serology at a peripheral level in leprosy endemic areas would require a simple test system. To ful¢ll that requirement, we have recently developed a simple dipstick assay for the detection of antibodies to PGL-I, which does not require any specialized equipment and makes use of 0928-8244 / 98 / $19.00 ß 1998 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved. PII: S 0 9 2 8 -8 2 4 4 ( 9 8 ) 0 0 0 4 9 -2 highly stable reagents, not depending on refrigeration [3] . However, in this test serum was used.
Here, we describe a further simpli¢cation of the dipstick assay, using whole blood. In addition, we report on the performance of the test carried out by a leprosy ¢eld worker in an endemic area in Brazil.
Materials and methods

Study population
The population studied included untreated and treated multibacillary (MB) (n = 123) and paucibacillary (PB) leprosy patients (n = 55), household contacts of leprosy patients (n = 42) and patients with skin diseases other than leprosy (n = 33) attending the Institute`Alfredo da Matta', Manaus, Brazil. MB leprosy patients were those with more then ¢ve skin lesions or a positive bacterial index (BI) in any of 4 skin smears. The MB group was composed of 43 lepromatous (LL), 38 borderline lepromatous (BL), 24 borderline (BB) and 18 tuberculoid borderline patients (BT). PB leprosy patients were those with up to ¢ve skin lesions and negative BI in all 4 skin smears. The PB group was composed of 12 indeterminate (I), 31 tuberculoid (TT) and 12 borderline tuberculoid patients (BT). This classi¢cation follows the World Health Organization (WHO) recommendation [4] . The contacts were persons living in the same household as the MB or PB cases.
Serum and blood samples were collected from all of the above mentioned study population (n = 253). Whole blood was collected by ¢nger-prick in heparinized capillary tubes.
In addition, serum from 112 healthy blood donors residing in Manaus, Amazonas was used as negative controls in the ELISA (see below) to determine the cut-o¡ value for positivity.
Dipstick assay
The dipstick assay for the detection of antibodies to PGL-I of M. leprae was used as described before [3] . The dipsticks bear two bands: an antigen band consisting of the M. leprae-speci¢c and immunodominant disaccharide epitope of phenolic glycolipid I (PGL-I) linked to BSA (disaccharide-BSA or DBSA) [5] and an internal control band consisting of anti-human IgM antibodies that bind IgM molecules from the serum. The antigen was provided by WHO/IMMLEP through Dr. J. Colston (National Institute for Medical Research, London, UK). The IgM detection reagent consists of a lyophilized monoclonal anti-human IgM antibody linked with a colloidal dye [6] . Brie£y, dipsticks were wetted in distilled water for 15 s and then incubated for 3 h in a reaction vial containing 0.2 ml of the reconstituted detection reagent and 4 Wl serum. At the end of the incubation period the dipsticks were rinsed with tap water and air-dried at ambient temperature. A reddish stained antigen band upon visual inspection indicates a positive reaction. The results were scored as positive when staining, irrespective of its intensity, was observed; no coloring was scored as negative.
When whole blood was used, the procedure followed was the same, except that 10 Wl of the blood sample was diluted, immediately after collection, in 200 Wl of the detection reagent. The dipstick assay was performed in Manaus, Brazil by a ¢eldworker whose normal duty was to collect skin smears from leprosy patients and who had no experience with serological assays.
ELISA
The ELISA for the detection of IgM antibodies to PGL-I of M. leprae was performed essentially as described previously [5] using DBSA as the semi-synthetic analogue of PGL-I. DBSA (0.1 Wg ml 3I ) was diluted in carbonate bu¡er (pH 9.6) and coated overnight at 37³C in a moist chamber, onto wells (50 Wl well 3I ) of Nunc-Immunoplates-II (Nunc, Denmark). As a control 0.1 Wg ml 3I bovine serum albumin (BSA) was used. Microtitre plates were blocked for 60 min with 100 Wl of 1% BSA in PBS containing 0.1% Tween 20 (PBST). After washing three times with PBST, the sera were diluted 1:300 in PBST containing 10% normal goat serum (NGS) and 50 Wl was added to each well. This was incubated at 37³C for 60 min and followed by another washstep. Peroxidase conjugated anti-human IgM conjugate (Capple/Organon Teknika, Turnhout, Belgium) was added (50 Wl well 3I ) at a 1:2000 dilution in PBST-10% NGS to the microtitre plate. After incu-bation at 37³C for 60 min, the washing procedure was repeated and 50 Wl of 0.1 M citrate-phosphate bu¡er containing 0.4 mg/ml O-phenylenediamine and 0.0066% hydrogen peroxide were added to each well. In order to control for plate-to-plate and day-to-day variation, a positive reference serum was included in triplicate on each plate. The color reactions of the entire plate were stopped with 50 Wl 2 N H P SO R when the optical density at 492 nm (OD RWPnm ) from a positive control serum reached an OD value of 0.6. ODs were measured in a spectrophotometer using a 492-nm ¢lter. All sera were tested in duplo and the ELISA results were expressed as mean absorbance of the duplicates. The ¢nal OD value of each serum sample was calculated by subtracting the OD value of wells coated only with BSA from the OD value of the test wells coated with DBSA. The cut-o¡ value for positivity was OD = 0.250, corresponding to the mean value of the presumably negative blood donors (n = 112) plus two times the standard deviation.
Statistical evaluation
The variation between the dipstick assay and the IgM ELISA was determined by calculating U values with 95% con¢dence intervals. U values express the agreement beyond chance. Generally, a U value of s 0.80 represents almost perfect agreement beyond chance [7] .
Results and discussion
The agreement between ELISA (continuous measurement) and dipstick assay (discrete result) critically depends on the cut-o¡ value of the ELISA. As can be seen in Fig. 1 , the concordance, sensitivity and speci¢city of the dipstick assay performed on serum in relation to the ELISA are all consistently high above cut-o¡ values of OD s 0.25. At the cut-o¡ value (OD = 0.25) used in this study a high agreement (96.5%, U = 0.89) was observed between the ELISA and the dipstick assay both performed with sera (n = 253). This cut-o¡ value resulted in a ELI-SA-positivity rate among healthy blood donors of 1.8% (2/112) which was comparable to the one pre- Fig. 1 . Performance characteristics of the dipstick assay using serum in relation to ELISA at di¡erent cut-o¡ values. Agreement between ELISA and dipstick assay = 94.1% (U = 0.85). MB = multibacillary, PB = paucibacillary.
viously reported (1.7%; 2/116) [3] . None of the blood donors was positive in the dipstick assay. These ¢nd-ings con¢rm previously reported results on sera from a geographically di¡erent population [3] . A similar high agreement was found comparing the dipstick assay performed on whole blood compared to the ELISA on the corresponding serum ( Table 1 ). The concordance was 94.1% (U = 0.85). Table 2 shows the results of the dipstick assay performed on paired samples of whole blood and serum. The agreement was 94.9% with a U value of 0.87. Together, these results con¢rm the good concordance between dipstick assay and ELISA results using sera, reported previously [3] and in addition show that the agreement is equally good when the dipstick assay for the detection of antibodies to PGL-I is performed on whole blood and under tropical ¢eld conditions.
The ELISA detected 39.3% (70/178), the dipstick 40.4% (72/178) of all leprosy patients using serum and 39.9% (71/178) using blood (Tables 1 and 2) ; these sensitivities were not signi¢cantly di¡erent from each other (M P test; all P s 0.8). It should be noted that the patient population included paucibacillary patients and treated patients, both known to have a low bacillary load and presenting low antibody titers [2] .
Samples from 19 individuals (7.5%) showed discrepant results in any of the three tests. These same samples produced the same inconsistent results between the assays upon repeated testing in the Netherlands (results not shown). The OD values found in ELISA with most of these sera were close to the cut-o¡ value for positivity (mean OD = 0.322, S.D.=0.210). Several explanations can be put forward to explain discrepancies between the results of the assays. A positive dipstick in combination with a negative ELISA result may be due to the more stringent nature of the ELISA requiring a stronger a¤n-ity for the antibody, as ELISA uses multiple washing with detergent to ensure tight binding of the antigen/ antibody complex. The di¡erences in dilution of the sample, 1:50 in dipstick vs. 1:300 in ELISA, may also favor sensitivity of the dipstick. On the other hand, substances present in blood/serum that may inhibit antigen/antibody interaction would favor sensitivity of ELISA compared to the dipstick assay. The discrepancies between dipstick results obtained with blood and serum from the same patient may be due to the height of the hematocrit which could effectively result in a di¡erent dilution of antibodies in whole blood compared to serum. The limited volume of the samples prevented further investigation of the precise nature of these few discrepant results.
In conclusion, the ¢ndings presented here show that whole blood can be used to perform the dipstick assay for the detection of antibodies to PGL-I of M. leprae and that this dipstick assay performs well under tropical ¢eld conditions. This facilitates the use of the test under ¢eld conditions by local health workers without the need of laboratory facilities. The next step will be to investigate the potential role of the dipstick test in the successful detection of leprosy in potential patients and its value as a tool to classify leprosy patients as PB or MB for treatment purposes.
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